2012
DOI: 10.1016/j.rbmo.2012.07.020
|View full text |Cite
|
Sign up to set email alerts
|

History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 36 publications
1
46
0
2
Order By: Relevance
“…Sharing sibling oocytes with the controls from donors documented not to harbor endometriosis, recipients with stage III-IV endometriosis (n = 25) were reported to have comparable pregnancy rates to controls (n = 33) without endometriosis [40]. In contrast, using a similar study design, with a larger sample size of 240 patients, lower implantation, clinical and live birth rates were reported in menopausal recipients with endometriosis compared to the controls [41]. In our study, we noted comparable implantation rates among the early- and late-stage disease and control groups refuting any detrimental effect of endometriosis on embryo viability and/or endometrial receptivity.…”
Section: Discussionmentioning
confidence: 99%
“…Sharing sibling oocytes with the controls from donors documented not to harbor endometriosis, recipients with stage III-IV endometriosis (n = 25) were reported to have comparable pregnancy rates to controls (n = 33) without endometriosis [40]. In contrast, using a similar study design, with a larger sample size of 240 patients, lower implantation, clinical and live birth rates were reported in menopausal recipients with endometriosis compared to the controls [41]. In our study, we noted comparable implantation rates among the early- and late-stage disease and control groups refuting any detrimental effect of endometriosis on embryo viability and/or endometrial receptivity.…”
Section: Discussionmentioning
confidence: 99%
“…Studies from In Vitro Fertilization (IVF) cycles have documented a decreased pregnancy rate (24, 25), which can be improved with gonadotropin releasing hormone agonist (GnRHa) suppression (26), surgery (27) or aromatase inhibitor therapy (28). While early studies on donor oocytes has suggested the primary defect associated with endometriosis may reside in the ovary and oocyte quality (29), larger and more recent studies have documented that defective implantation is also likely involved (30). Prapas and co-workers studied the result of 240 cycles, placing sibling oocytes from the same donor into women with or without endometriosis.…”
Section: Endometriosis and Infertility – What Is The Evidence?mentioning
confidence: 99%
“…Prapas and co-workers studied the result of 240 cycles, placing sibling oocytes from the same donor into women with or without endometriosis. Adjusted odds ratio (95% CI) showed reduced implantation (0.78 (0.67-0.91)), clinical pregnancy rate (0.22 (0.08-0.57)), ongoing pregnancy (0.11 (0.03-0.35)), and live birth rate (0.19 (0.09-0.38)) for women with endometriosis (30). …”
Section: Endometriosis and Infertility – What Is The Evidence?mentioning
confidence: 99%
“…Several clinical studies have indicated a decreased implantation rate in endometriosis patients undergoing IVF [73,74,75], and a meta-analysis of 27 studies demonstrated significantly lower implantation and clinical pregnancy rates in patients with severe endometriosis [76]. To exclude factors associated with oocyte and embryo quality, a prospective study using sibling oocytes from the same donor demonstrated that recipients with endometriosis had significantly lower implantation and pregnancy rates than control recipients [77]. However, not all related studies have reached the same conclusion, instead generally attributing poorer IVF outcome in endometriosis patients to compromised oocyte and embryo quality [78,79,80,81].…”
Section: Chronic Niche Inflammation In Endometriosis Developmentmentioning
confidence: 99%